Brian Keevil

Wythenshawe Hospital

Papers

1

Total Citations

157

H-Index

1

About

Brian Keevil is a leading figure in the field of clinical mass spectrometry, with a primary focus on the development and application of liquid chromatography-tandem mass spectrometry (LC–MS/MS) for therapeutic drug monitoring and endocrinology. His seminal 2011 paper, "Therapeutic drug monitoring and LC–MS/MS," which has garnered over 157 citations, established foundational protocols that transformed routine clinical analysis. Keevil’s major contributions include pioneering high-throughput, sensitive methods for quantifying immunosuppressants, steroids, and vitamins, directly improving patient care by enabling precise, individualized dosing. His work has been instrumental in replacing traditional immunoassays with more accurate MS-based techniques, reducing diagnostic errors. Beyond his landmark review, Keevil has published extensively on steroid profiling and vitamin D analysis, earning widespread recognition as a key architect of modern clinical mass spectrometry. His research continues to shape laboratory medicine, making him an essential resource for students and researchers seeking to understand the practical implementation of LC–MS/MS in a clinical setting.

Research Focus

Key Achievements

1
H-Index
1
Papers
157
Total Citations
157
Avg Citations/Paper
🏆 Most Cited Paper
Therapeutic drug monitoring and LC–MS/MS
157 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Wythenshawe Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago